Dr. Munro is a Clinical Professor in the Department of Obstetrics and Gynecology at the David Geffen School of Medicine at UCLA, in Los Angeles, California. Dr. Munro’s clinical and research interests are focused on disorders of the uterus, adnexae, and surrounding structures, including diagnosis, medical management, and, when needed, minimally invasive approaches, such as hysteroscopic, laparoscopic, vaginal, or image-guided. Dr Munro has developed systems and techniques for performing virtually all hysteroscopic and other intrauterine procedures in an office environment, solely with local anesthesia, an approach that adds safety, frees up operating rooms, and reduces costs for both patients and the health care system (Link). He has demonstrated skills in surgical education and training and was the Principal Investigator for the  EMIG Manual Skills Construct Validation Trial,  a joint effort of the AAGL, CREOG, and the American College of Obstetricians and Gynecologists for gynecologic endoscopy training and high-stakes testing. The results of this trial and the associated development of educational content and cognitive testing have created a process that is now one of the requirements for certification by the American Board of Obstetrics and Gynecology. He was a Co-founder and previous Chair of the  FIGO Committee on Menstrual Disorders and Related Health Impacts which has been responsible for the development and publication of the two FIGO AUB Systems for Symptoms and Classification of causes, the FIGO Leiomyoma Classification System, and the  FIGO Ovulatory Disorders Classification System, now used worldwide by investigators, clinicians, and educators. Dr Munro was a founding co-Chair of the SEUD Abnormal Uterine Bleeding Task Force.

Because he is a practitioner focusing on the underinvestigated and underserved problem of chronic pelvic pain (CPP), Dr Munro helped organize a process for developing FIGO-supported CPP systems, similar to those developed for AUB. This process, produced in association with the International Pelvic Pain Society, involved stakeholders from around the world and resulted in the  R U MOVVING SOMe System published in fall 2025, the first of two such systems designed to facilitate appropriate evaluation and diagnosis for women with CPP.

In 2020, Dr Munro co-founded the Women's Health Research Collaborative (WHrC), a not-for-profit organization dedicated to advocacy and research on underserved and underinvestigated conditions affecting women's reproductive health. These include acute uterine bleeding, chronic heavy menstrual bleeding, iron deficiency, and surgically induced endometrial trauma and associated adverse obstetrical outcomes. The WHrC has funded research into iron deficiency and intrauterine adhesions associated with surgically induced endometrial trauma, and functioned as an advocate for women with acute and chronic abnormal uterine bleeding in the reproductive years.  Several papers have been published, including an extensive systematic review and selected meta-analyses, in  November 2025 in Human Reproduction Update.

Dr Munro has published more than 150 papers in the peer-reviewed literature that have been cited more than 15,000 times, resulting in a  Google Scholar h-index of 57 and an i10 index of 128.  Included in the publications are 45 authored or coauthored chapters, two edited bound volumes, and three books, including  Abnormal Uterine Bleeding, released by Cambridge University Press, and with Professor Victor Gomel, a two-volume textbook for minimally invasive uterine and adnexal surgeons called  Reproductive and Reconstructive Gynecologic Surgery. Dr Munro is an Associate Editor for Human Reproduction Update, on the Editorial Board of the Journal of Minimally Invasive Gynecology, and a reviewer for numerous other peer-reviewed specialty journals. He has served the American Association of Gynecologic Laparoscopists (AAGL) as a member of the Board of Trustees (2000-2002) and as the inaugural chair of the AAGL Practice Committee, charged with developing evidence-based practice guidelines for minimally invasive approaches to gynecology. 

As a consultant to the pharmaceutical and device industry, Dr. Munro advises on device development, product research design, new business development, marketing programs, economic modeling, and legal and regulatory issues. These services have culminated in device development and modification, product submissions, and presentations to the relevant FDA panel. Included in Dr. Munro’s current or past corporate clients are a spectrum of companies ranging from early stage to multinational corporate entities, such as Abbvie Inc, Abbott, Aegea Inc, American Regent, Andronic Devices, Avana Health, Boston Scientific, Caldera Medical, Channel Medical, ConMed Inc, CooperSurgical Inc,  Covidien, Cross Bay Medical, CSL Vifor, Daiichi Sankyo Pharmaceuticals,  EndoSee, Ethicon Women’s Health and Urology, Ethicon Endosurgery,  Graphic Surgery LLC, Gynesonics Inc, Hologic Inc, Idolman US and Canada, Karl Storz Endoscopy Americas, Myovant Inc, Novacept, Okon Medical, Pharmacosmos,  Rejoni Inc, Shield Therapeutics, Sumitomo, WOMED, Veldana, and Vifor Pharma, now CSL Vifor. Dr Munro holds, or coholds  eight device patents. 

A Fellow of the American College of Obstetricians and Gynecologists (ACOG), and the Royal College of Surgeons of Canada (FRCSC), Dr Munro was made a Fellow of the Royal College of Obstetricians and Gynecologists (FRCOG) "ad eundem" in London UK in 2023.

Click To Paste

Click To Paste

Click To Paste